Robust therapeutic effects on COVID-19 of novel small molecules: Alleviation of SARS-CoV-2 S protein induction of ACE2/TMPRSS2, NOX2/ROS, and MCP-1

By sjmartinez • October 4, 2022

Youn JY, Wang J, Li Q, Huang K, Cai H. Robust therapeutic effects on COVID-19 of novel small molecules: Alleviation of SARS-CoV-2 S protein induction of ACE2/TMPRSS2, NOX2/ROS, and MCP-1. Front Cardiovasc Med. 2022 Sep 15;9:957340. doi: 10.3389/fcvm.2022.957340. PMID: 36187008; PMCID: PMC9520320.

Tags: acute respiratory distress syndrome (ARDS), Cardiology/Epi, covid-19, endothelial dysfunction, NADPH oxidase isoform 2 (NOX2), Publications, SARS-CoV-2

Association of neighborhood-level socioeconomic disadvantage and Life’s Essential 8 in early pregnancy

Venkatesh KK, Grobman WA, Huang X, Yee LM, Catov J, Simhan H, Haas DM, Mercer B, Reddy U, Silver RM, Levine LD, Chung J, Saade[...]

MRI-assessed Dynamic Hyperinflation Induced by Tachypnea in Chronic Obstructive Pulmonary Disease: The SPIROMICS-HF Study

Zhang X, Cooper CB, Prince MR, Ambale-Venkatesh B, Agarwal PP, Backman MC, Bluemke DA, Couper D, Dashnaw SM, Finn JP, Hansel NN, Hoffman EA, Jambawalikar[...]

Interventions for adult congenital heart disease

Cepas-Guillén P, Flores-Umanzor E, Horlick E, Aboulhosn J, Benson L, Freixa X, Houde C, Rodés-Cabau J. Interventions for adult congenital heart disease. Nat Rev Cardiol.[...]